findmyKOL
Clinical trialNCT01002742CompletedPhase 3Interventional

Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)

SponsorMedical College of WisconsinEnrollment236Graft-versus-Host DiseaseImmune System Disorders
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Mary Horowitz, MD

    Center for International Blood and Marrow Transplant Research

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • City of Hope National Medical Center

    Duarte, California, United States

  • University of California San Diego Medical Center

    La Jolla, California, United States

  • Stanford Hospital and Clinics

    Stanford, California, United States

  • Colorado Blood Cancer Institute

    Denver, Colorado, United States

  • University of Florida College of Medicine

    Gainesville, Florida, United States

  • Bmt Program at Northside Hospital

    Atlanta, Georgia, United States

  • Ann & Robert Lurie Children'S Hospital of Chicago

    Chicago, Illinois, United States

  • Rush University Medical Center

    Chicago, Illinois, United States

  • Indiana Bmt at Beech Grove

    Beech Grove, Indiana, United States

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa, United States

  • Johns Hopkins University

    Baltimore, Maryland, United States

  • University of Maryland Medical Systems

    Baltimore, Maryland, United States

  • Dfci, Massachusetts General Hospital

    Boston, Massachusetts, United States

  • Dana Farber Cancer Institute, Brigham & Women'S Hospital

    Boston, Massachusetts, United States

  • Tufts Medical Center

    Boston, Massachusetts, United States

  • University of Michigan Medical Center

    Ann Arbor, Michigan, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Washington University, Barnes Jewish Hospital

    St Louis, Missouri, United States

  • Hackensack Univ. Medical Center

    Hackensack, New Jersey, United States

  • Memorial Sloan-Kettering Cancer Center

    New York, New York, United States

  • Weill Cornell Medical College, Ny Presbyterian Hospital

    New York, New York, United States

  • University of North Carolina Hospital at Chapel Hill

    Chapel Hill, North Carolina, United States

  • Levine Children'S Hospital, Carolinas Medical Center

    Charlotte, North Carolina, United States

  • Duke University Medical Center

    Durham, North Carolina, United States

  • Ohio State University

    Columbus, Ohio, United States

  • Oregon Health and Science University

    Portland, Oregon, United States

  • University of Pennsylvania Cancer Center

    Philadelphia, Pennsylvania, United States

  • Medical University of South Carolina

    Charleston, South Carolina, United States

  • Avera Hematology & Transplant Center

    Sioux Falls, South Dakota, United States

  • Baylor University Medical Center

    Dallas, Texas, United States

  • University of Texas, Md Anderson Cancer Research Center

    Houston, Texas, United States

  • Texas Transplant Institute

    San Antonio, Texas, United States

  • Virginia Commonwealth University

    Richmond, Virginia, United States

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2010
Primary completion
31 Jan 2012
Completion
30 Jun 2013
Last update posted
4 Jan 2023
Registered enrollment
236
Registry id
NCT01002742

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.